
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [MRK] Merck & Co., Inc.
Data updated 2025-Jul-03 (Thursday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Jul-03 Thursday
Open | $82.55 | High | $82.60 +0.06% |
---|---|---|---|
Close | $80.93 | Low | $80.70 -2.24% |
Volume | 7.73 Million 1.11x | Volatility | 2.35% |
Change |
$-1.46
-1.77%
|
Streak | ↓ 1 days -1.77% |
20d SMA | $80.05 +1.1% | 50d SMA | $79.28 +2.1% | 100d SMA | $83.47 -3.0% | 200d SMA | $93.24 -13.2% |
RSI | 54 | MACD | 0.21 | ADX | 14.1 | Stochastic Oscillator | 77.2 65.9 |
CCI | 88.9 | ATR | 1.95 | OBV | 830 Million | Chaikin A/D | 603 Million |
Market Cap | 321 B | PEG Ratio | 0.1 | Trailing P/E | 905 | Forward P/E | 14.9 |
Price/Sales (ttm) | 5.37 | Price/Book (mrq) | 8.54 | EV/Revenue (ttm) | 5.81 | EV/EBITDA (ttm) | 50.5 |
% Held by Insiders | 0.07% | % Held by Institutions | 78.58% | Shares Short | 19.6 M | Shares Short (prior month) | 16.6 M |
Short Ratio | 1.77 | Short % of Outstanding | 0.77% | Short % of Float | 0.77% | Shares Short Change (mom) | +18.0% |
Revenue/Share (ttm) | $23.69 | Profit Margin (ttm) | 0.61% | Operating Margin (ttm) | 0.08% | EBITDA (ttm) | 8.3 B |
Diluted EPS (ttm) | $0.14 | Current Ratio (mrq) | 1.25 | Return on Assets (ttm) | 2.64% | Return on Equity (ttm) | 0.90% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 5.80% | Operating Cash Flow (ttm) | 13 B | Free Cash Flow (ttm) | 2.13 B | |
Choose view type
Daily Performance for Merck & Co., Inc.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Merck & Co., Inc. up to close of 2025-Jul-03 at $80.93
2-month Performance Benchmarks for Merck & Co., Inc.:
Related to Merck & Co., Inc.
Information for Merck & Co., Inc.
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-03 on Google
SEC Reports : Quarterly reports around 2025-Jul-03 on SEC Edgar
Compare Merck & Co., Inc. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Merck & Co., Inc.
Industry : Pharmaceuticals industry performance which includes Merck & Co., Inc.